AzTrials
AzTrials

Comparison of US Bilateral Erector Spinae Plane Block, US Bilateral Quadratus Lumborum Block and Lumbar EpiduralNCT06397300

Comparison of US Bilateral Erector Spinae Plane Block, US Bilateral Quadratus Lumborum Block and Lumbar Epidural for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy

A study testing bilateral Ultrasound guided erector spinae plane (ESP) block, quadratus lumborum block and lumbar epidural in people with Comparison of US Bilateral Erector Spinae Plane Block, US Bilateral Quadratus Lumborum Block and Lumbar Epidural, run by National Cancer Institute, Egypt at 2 sites in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The investigators hypothesize that US Bilateral Erector Spinae Plane Block, US Bilateral Quadratus Lumborum Block and Lumbar Epidural for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy resulting in reducing myofascial pain and opioid consumption. Read more about this study

Who is it for?
Ages 18 to 65 years, women only
What is being tested?
bilateral Ultrasound guided erector spinae plane (ESP) block, quadratus lumborum block and lumbar epidural
Could I receive a placebo?
No, everyone receives an active treatment
How many people
90 participants
Where
2 sitesEgypt
Study dates
1 Sep 2023to 1 Apr 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • ASA class II , III and IV
  • 18yrs ≥ Age ≤ 65yrs
  • Body mass index (BMI): 20-40 kg/m2
  • Patient undergoing total abdominal hysterectomy under general anesthesia.

Who cannot join

  • Age < 18yrs or > 65yrs
  • Patient refusal
  • known sensitivity or contraindication to drugs used in the study
  • Contraindication to regional anesthesia e.g. local sepsis or coagulopathy
  • History of psychological disorders and chronic pain

Trial locations and contacts

2 sites in 1 country.

Egypt2 sites
  • National cancer Insititute

    Cairo, 11796

  • Ahmed Mohamed Soliman

    Giza

Other trials in Egypt

About this study

Official title: Comparison of Ultrasound Guided Bilateral Erector Spinae Plane Block, Ultrasound Guided Bilateral Quadratus Lumborum Block and Lumbar Epidural for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy ; a Prospective Randomized Clinical Trial

The investigators hypothesize that US Bilateral Erector Spinae Plane Block, US Bilateral Quadratus Lumborum Block and Lumbar Epidural for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy resulting in reducing myofascial pain and opioid consumption.

Read the detailed description

Background and Rationale:

Gynecological cancers comprise 10-15% of women's cancers, mainly affecting women post-reproductive age but posing threats to fertility for younger patients.

The goal of postoperative pain control is to reduce the negative consequences associated with acute postsurgical pain and help the patient make a smooth transition back to normal function. Traditionally, opioid analgesic therapy has served as the mainstay of treatment for acute postoperative pain. However, the recent rise in morbidity and mortality associated with opioid misuse has led to increasing demands for more investigative efforts into developing pain treatment strategies that place more emphasis on using a multimodal approach. These efforts have proved to be challenging, as the subjective nature of pain perception further complicates the ability to achieve satisfactory pain control. Furthermore, specific patient comorbidities and social factors may predispose patients to have increased pain perception.

Approximately 75 percent of patients who undergo surgery experience acute postoperative pain, which is often medium-high in severity. Less than half of patients undergoing surgery report adequate postoperative pain relief. This percentage presents a significant problem as inadequate postoperative pain control may lead to adverse physiologic effects among patients in the immediate postoperative period and place them at increased risk of developing chronic pain associated with the procedure. Severe persistent postoperative pain affects 2 to 10 percent of adults.

Multiple peer-reviewed publications address the topic of postoperative pain control in gynecologic oncology surgery. Because many of these surgeries require large laparotomy incisions, patients frequently receive intravenous opioids for pain control. Patient-controlled analgesia, or PCAs, are often used as the mechanism of delivery as they allow patients to deliver pain medications based on their perceived needs. Intravenous opioids are associated with undesired side effects, including nausea, pruritus, hallucinations, and delay in the return of bowel function, which may ultimately lead to prolonged hospitalization and extended recovery times. The use of ultrasonographic technology in regional anesthesia practice has not only eased the application of nerve blocks and interfascial blocks but also led to the definition and practical use of many new interfascial blocks. Thoracoabdominal/thoracolumbar blocks - also named as truncal blocks, have gained popularity recently with the number of such defined blocks increasing substantially.

Erector spinae plane block (ESPB) is an interfacial plane block that provides truncal analgesia. Originally described in 2016 as an analgesic technique for thoracic neuropathic pain, ESPB has since been applied in abdominal procedures. While the mechanism of ESBP requires further investigation, some postulate the target to be the ventral rami of spinal nerves. Recent randomized trials have showed ESPB to reduce pain scores in cardiac and breast surgeries.

Since Blanco et al. first described the Quadratratus lumborum block (QLB) in 2007, its use in abdominal surgeries has been shown to be superior to the transversus abdominis plane (TAP) block for postoperative analgesia in this group of patients. Dam et al. defined the transmuscular approach (QL-TM) for this block.

Regarding major lower abdominal surgery, epidural analgesia was shown to be the gold standard time-tested technique for providing postoperative analgesia, but due to its possible complications, contraindications, there is a need for other equally efficient analgesic techniques.

Study Design:

This is a prospective randomized clinical trial. The patients will be randomly assigned into three equal comparable groups, each of them contains 30 patients, using computer-generated random numbers.

Each patient signed an informed consent form for block interventions and participation in the study. Patients 'age between 18 and 65 years with American Society of anesthesiology (ASA) physical status II-III-IV, who will be scheduled for an elective open total abdominal hysterectomy will be included in the study. Ultrasound guided nerve blocks and epidural injection will be applied after induction of general anesthesia.

The first group will receive bilateral Ultrasound guided erector spinae plane (ESP) block which is a relatively new block technique and many case reports show the efficacy of this technique for different uses. To perform ESP block in the lateral position bilaterally ,the skin will be disinfected with 70% alcohol bilaterally and a linear transducer is placed in a longitudinal parasagittal orientation and erector spinae muscle, trapezius muscle, rhomboid major muscle (rhomboid major muscle is absent below T6 level) and transverse process are visualized and local anesthetic is injected (0.25% bupivacaine 20 ml in each side) in the area between transverse process and erector spinae muscle at T10 level [19]. Hadi Ufuk Yِrükoğlu et al have been using this technique in their clinic for many different indications and the results are promising.

The second group of patients will receive quadratus lumborum block which will be done in the lateral decubitus position. Right block will be performed; the patient will then repositioned for the left block. An ultrasound device will be used, in which a convex probe with broadband (5-8 MHz) will be placed in the mid-axillary line just above the iliac crest to identify the three muscles of the anterior abdominal wall (transversus abdominis, internal oblique, and external oblique). Then, scan dorsally to keep the transverse orientation until seeing the aponeurosis of the transverses abdominus muscle and by following this aponeurosis, QL muscle will be visualized with its attachment to the lateral edge of the transverse process of the L2 vertebral body and visualize the thoracolumbar fascia at the lateral edge of the QL muscle. The view of the psoas major muscle anteriorly, the erector spinae muscle posteriorly, and the QL muscle adherent to the apex of the transverse process result in a well-known view of a Shamrock with three leaves (trifoliate). A spinal needle (20G) will be inserted in-plane from the anterior to posterior direction, and the tip of the needle will be advanced anterior to the QL muscle. The target site for injection is the plane between the quadratus lumborum and psoas major muscles. A test dose of 1 mL of saline will be injected for hydro visualization of the needle tip position and for confirming its correct positioning. This will be followed by injection of 0.25% bupivacaine 20 ml in each side . The dose should not exceed the safe limits (2 mg.kg of bupivacaine). Bupivacaine will be applied (on each side) between the quadratus lumborum muscle and the psoas major muscle in the interfascial plane, using the in-plane technique.

The third group of patients will receive lumbar epidural under strict aseptic precautions, lumbar epidural was performed for patients in Group III using a 16-gauge Touhy epidural needle by a median approach. The T12 - L1 or L1 - L2 interspaces was chosen for the injection.

The epidural space identified by the loss of resistance technique. The catheter was advanced 4 cm cephalad. When the aspiration test results for blood and cerebrospinal fluid were negative, a test dose of (3 mL) 2% lidocaine with 1: 200,000 adrenaline was given after the placement of the epidural catheter.

Then this will be followed by injection of 0.25% bupivacaine 15 ml as a single injection after induction of general anesthesia .

Study Methods:

Population of the study:

Patients scheduled for elective open total abdominal hysterectomy at the National Cancer Institute who meet the inclusion criteria.

Background and demographic characteristics:

90 patients ASA II-III-IV scheduled for elective open total abdominal hysterectomy under general anaesthesia.

Methodology:

Patients between 18-65 years old who scheduled for total abdominal hysterectomy will be enrolled in the study. Approval of the ethical committee and informed written consent from all patients will be issued. Patients will be given a full and detailed explanation of the intended study protocol and will be informed about the potential benefits of the development of a successful technique as well as the potential side-effects.

Study protocol Patients will be assessed the day before surgery in a preoperative visit for evaluating their medical status, laboratory investigations and for fulfilling all the above inclusion and exclusion criteria.

The patients will be instructed how to report pain by means of the visual analogue scale (VAS) score rating, in which 0 = "no pain" and 10 = "worst possible pain"[22]. All groups of the study will be premedicated with I.V 0.02 mg/kg midazolam 30 minutes preoperatively. Heart rate (HR), mean arterial blood pressure (MBP), oxygen saturation (SO2%) will be monitored before induction of anaesthesia (base line values), immediately before surgical incision and at 30 min intervals intraoperative.

Anesthesia Management:

Induction of general anaesthesia in all study groups will be performed using a regimen of IV 1 μcg/kg fentanyl and IV 2 mg /kg propofol. Tracheal intubation will be facilitated using 0.5 mg/kg IV of Atracurium. Anesthesia will be maintained with inhaled isoflurane with MAC 1.2-1.4% in oxygen enriched air (FiO 2=0.5) and top up doses of atracurium (0.1 mg/kg) IV will be administered as required. All patients will be mechanically ventilated aiming to keep end tidal carbon dioxide within the range of 30-35 mmHg. Additional bolus doses of fentanyl 0.5µg/kg will be given if the mean arterial blood pressure or heart rate rises above 20% of baseline values. The total intraoperative fentanyl consumption will be recorded in all study groups.

Ringer acetate will be infused in order to replace any fluid deficit, maintenance and losses.

Hypotension will be defined as MAP less than 60mmHg or less than 30% from baseline. Severe (i.e., MBP less than 60 mmHg) or prolonged (i.e., duration greater than or equal to 2 min) episodes of hypotension will be treated with 0.9% normal saline and/or 5mg ephedrine in incremental doses in order to maintain mean blood pressure above 70 mmHg. At the end of surgery the residual neuromuscular blockade will be reversed using neostigmine (0.05 mg/kg) and atropine (0.02 mg/kg), and extubation will be performed after complete recovery of the airway reflexes. The patients will be transferred to the post anaesthesia care unit where MAP, heart rate and VAS pain score will be noted immediately on arrival and at 4, 8, 12 and 24 h postoperatively. Rescue analgesia will be provided in the form of IV morphine 3 mg boluses if the pain score was >3. The total amount of morphine given in 24 h will be recorded in the three groups. Thereafter, the patients will be shifted to ward and will be given acetaminophen 1 g IV every 8 hours.

Being tested
bilateral Ultrasound guided erector spinae plane (ESP) block, quadratus lumborum block, lumbar epidural
Keywords
Analgesics, Opioids, Postoperative Pain, Nerve block, ultrasound, Hysterectomy, cancer, ovarian neoplasm, uterine carcinoma
Medical subject headings
Pain, Postoperative, Neoplasms, Ovarian Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • bilateral Ultrasound guided erector spinae plane (ESP) blockProcedure or surgery

    To perform ESP block in the lateral position bilaterally ,the skin will be disinfected with 70% alchol bilaterally and a linear transducer is placed in a longitudinal parasagittal orientation and erector spinae muscle, trapezius muscle, rhomboid major muscle (rhomboid major muscle is absent below T6 level) and transverse process are visualized and local anesthetic is injected (0.25% bupivacaine 20 ml in each side) in the area between transverse process and erector spinae muscle at T10 level.

  • quadratus lumborum blockProcedure or surgery

    In the lateral decubitus position. Right block will be performed; the patient will then repositioned for the left block. An ultrasound device with a convex probe (5-8 MHz) will be placed in the mid-axillary line just above the iliac crest. Then, scan dorsally to keep the transverse orientation until seeing the aponeurosis of the transverses abdominus muscle and by following this aponeurosis, QL muscle will be visualized with its attachment to the lateral edge of the transverse process of the L2 vertebral body and visualize the thoracolumbar fascia at the lateral edge of the QL muscle. A spinal needle (20G) will be inserted in-plane from the anterior to posterior direction, and the tip of the needle will be advanced anterior to the QL muscle. The target site for injection is the plane between the quadratus lumborum and psoas major muscles. This will be followed by injection of 0.25% bupivacaine 20 ml in each side.

  • lumbar epiduralProcedure or surgery

    under strict aseptic precautions, lumbar epidural was performed for patients in Group III using a 16-gauge Touhy epidural needle by a median approach. The T12 - L1 or L1 - L2 interspaces was chosen for the injection.

    The epidural space identified by the loss of resistance technique. The catheter was advanced 4 cm cephalad. When the aspiration test results for blood and cerebrospinal fluid were negative, a test dose of (3 mL) 2% lidocaine with 1: 200,000 adrenaline was given after the placement of the epidural catheter.

    Then this will be followed by injection of 0.25% bupivacaine 15 ml as a single injection after induction of general anesthesia.

Study groups in NCT06397300
Study groupRoleWhat they receive
bilateral Ultrasound guided erector spinae plane (ESP) blockActive comparator. To perform ESP block in the lateral position bilaterally, a linear transducer is placed in a longitudinal parasagittal orientation and erector spinae muscle, trapezius muscle, rhomboid major muscle and transverse process are visualized and local anesthetic is injected (0.25% bupivacaine 20 ml in each side) in the area between transverse process and erector spinae muscle at T10 level.
Receives: Procedure: bilateral Ultrasound guided erector spinae plane (ESP) block
quadratus lumborum blockActive comparatorIn the lateral decubitus position. Right block will be performed; the patient will then repositioned for the left block. An ultrasound device with a convex probe (5-8 MHz) will be placed in the mid-axillary line just above the iliac crest. Then, scan dorsally to keep the transverse orientation until seeing the aponeurosis of the transverses abdominus muscle and by following this aponeurosis, QL muscle will be visualized with its attachment to the lateral edge of the transverse process of the L2 vertebral body and visualize the thoracolumbar fascia at the lateral edge of the QL muscle. A spinal needle (20G) will be inserted in-plane from the anterior to posterior direction, and the tip of the needle will be advanced anterior to the QL muscle. The target site for injection is the plane between the quadratus lumborum and psoas major muscles. This will be followed by injection of 0.25% bupivacaine 20 ml in each side.
Receives: Procedure: quadratus lumborum block
lumbar epiduralActive comparatorunder strict aseptic precautions, lumbar epidural was performed for patients in Group III using a 16-gauge Touhy epidural needle by a median approach. The T12 - L1 or L1 - L2 interspaces was chosen for the injection. The epidural space identified by the loss of resistance technique. The catheter was advanced 4 cm cephalad. When the aspiration test results for blood and cerebrospinal fluid were negative, a test dose of (3 mL) 2% lidocaine with 1: 200,000 adrenaline was given after the placement of the epidural catheter. Then this will be followed by injection of 0.25% bupivacaine 15 ml as a single injection after induction of general anesthesia.
Receives: Procedure: lumbar epidural

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Total postoperative opioid consumption

    Total postoperative morphine consumption till the first 24 hours postoperatively

    Measured: first 24 hours postoperatively

Secondary outcomes (5)
  1. Ramsay scores

    The (1 = anxious or restless or both; 2 = cooperative, orientated, and tranquil; 3 = responding to commands; 4 = brisk response to stimulus; 5 = sluggish response to stimulus; and 6 = no response to stimulus)

    Measured: at 0, 4, 8, 12, and 24 postoperatively.

  2. Visual analogue scale VAS

    VAS score 0 no pain to 10 maximum pain

    Measured: 0, 4, 8, 12 and 24 postoperatively.

  3. Total intraoperative fentanyl consumption

    dose of fentanyl consumption

    Measured: intraoperative

  4. mean arterial blood pressure.

    changes in mean arteria blood pressure

    Measured: intraoperative and 0, 4, 8, 12 and 24 postoperatively.

  5. Postoperative nausea and vomiting

    Postoperative nausea and vomiting as side effects of morphine

    Measured: 24 hours Postoperative

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted2 May 2024
  2. Study start1 Sep 2023
  3. Primary completion1 Mar 2024
  4. Study completion1 Apr 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Model description
To determine the analgesic effect of US Bilateral Erector Spinae Plane Block, US Bilateral Quadratus Lumborum Block and Lumbar Epidural for Postoperative Analgesia in Patients Undergoing Total Abdominal Hysterectomy regarding the following: 1. Post-operative opioid (morphine) consumption in the 1st 24 hours 2. Postoperative Numeric Pain Rating Scale. 3. Effect on hemodynamics: Mean arterial blood pressure and Heart rate. 4. Intraoperative fentanyl consumption. 5. Duration of analgesic effect
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
90 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06397300
Sponsor's protocol ID
AP2312-201-095
Other IDs
IRB00004025
Status last verified
Apr 2024
First submitted
18 Apr 2024
Last updated
2 May 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided: till publication

Questions about this trial

What is this clinical trial studying?

A study testing bilateral Ultrasound guided erector spinae plane (ESP) block, quadratus lumborum block and lumbar epidural in people with Comparison of US Bilateral Erector Spinae Plane Block, US Bilateral Quadratus Lumborum Block and Lumbar Epidural, run by National Cancer Institute, Egypt at 2 sites in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 2 May 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Total postoperative opioid consumption (time frame: first 24 hours postoperatively). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 May 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in